BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17257362)

  • 1. Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.
    Holley JL; Bailey S
    Hemodial Int; 2007 Jan; 11(1):96-8. PubMed ID: 17257362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
    Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
    Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function.
    Gabutti L; Mosconi E; Pellegrini L; Duchini F; Marone C
    J Nephrol; 2006; 19(2):183-8. PubMed ID: 16736417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
    Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
    Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
    Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
    ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience.
    Al-Hwiesh AK
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):593-602. PubMed ID: 18580019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy.
    Donati G; Colì L; Cianciolo G; La Manna G; Cuna V; Montanari M; Gozzetti F; Stefoni S
    Artif Organs; 2012 Jan; 36(1):21-8. PubMed ID: 21848863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin.
    Al-Hwiesh AK; Abdul-Rahman IS
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):239-47. PubMed ID: 17496402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method.
    Zhang P; Yuan J; Tan H; Lv R; Chen J
    Blood Purif; 2009; 27(2):206-11. PubMed ID: 19176949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
    Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G
    Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exit of catheter lock solutions from double lumen acute haemodialysis catheters--an in vitro study.
    Sungur M; Eryuksel E; Yavas S; Bihorac A; Layon AJ; Caruso L
    Nephrol Dial Transplant; 2007 Dec; 22(12):3533-7. PubMed ID: 17898024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
    Grudzinski L; Quinan P; Kwok S; Pierratos A
    Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the heparin lock concentration affect hemodialysis catheter patency?
    Ivan DM; Smith T; Allon M
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1458-62. PubMed ID: 20498241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
    Lok CE; Appleton D; Bhola C; Khoo B; Richardson RM
    Nephrol Dial Transplant; 2007 Feb; 22(2):477-83. PubMed ID: 17018541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadvertent postdialysis anticoagulation due to heparin line locks.
    Pepper RJ; Gale DP; Wajed J; Bommayya G; Ashby D; McLean A; Laffan M; Maxwell PH
    Hemodial Int; 2007 Oct; 11(4):430-4. PubMed ID: 17922740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catheter lock solution--taurolock for prevention of catheter-related bacteremia in hemodialysis patients].
    Geron R; Tanchilevski O; Kristal B
    Harefuah; 2006 Dec; 145(12):881-4, 943. PubMed ID: 17220025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.